Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
síbiotech is a Latvian biotechnology company focused on the extraction, research, and production of natural bioactive compounds and pharmaconutritional products. The company uses supercritical CO2 extraction, microalgae cultivation in closed photobioreactors, lyophilisation, and in-house softgel encapsulation to develop concentrated botanical and algal ingredients. Its marketed products include HIPPOCOR® and other nutraceutical formulations based on sea buckthorn, flaxseed, microalgae, and additional plant-derived compounds. The company also develops extraction and formulation solutions for partners and has reported clinical and bioavailability studies around HIPPOCOR®. síbiotech appears to operate as a private, active health-focused biotech/nutraceutical business rather than a traditional therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on síbiotech.